Which companies discussed GLP-1 Drugs in Financials in earnings calls?
39 companies mentioned glp-1 drugs across 56 earnings calls in Financials over the past year, spanning 1 sectors. The most active were VNV Global AB (publ) (4 calls), Reinsurance Group of America, Incorporated (3 calls), Unum Group (3 calls). The table below ranks every company by how often the theme came up, with direct links to each transcript.
Mentions over time
Data table
| Quarter | Calls mentioning GLP-1 Drugs |
|---|---|
| 2024Q4 | 9 |
| 2025Q1 | 10 |
| 2025Q2 | 8 |
| 2025Q3 | 12 |
| 2025Q4 | 15 |
| 2026Q1 | 17 |
| 2026Q2 | 8 |
| 2026Q3 | 15 |
Companies ranked by mentions
Representative quotes
…mystery to people for many decades. Health innovation is happening at a rapid pace. There's cancer treatments, there's longevity treatments, GLP-1s, all the things you read about. Private credit has been -- to a degree, highly innovative. It's a new source of capital that…
…leading healthcare place to serve people's health and financial goals in a larger individual market. It means more than insurance. It means GLP-1s. It means all the supplements that people buy, it means all the lifestyle things that people buy in order to impact their health…
…monitor and we look at as we see the trends, but it's hard to tell. The medical advancements for sure. I mean, GLP-1 is the one that absolutely comes up the most as we're talking and looking at a lot of our research. There…
…that time. There has been an increase in the second part there. So that's a combination therapy with the GLP and the amylin. That moved into a Phase IIb trial. So about a 25% probability when last reported. It's now 39%. If it's successful…
Frequently asked questions
What is GLP-1 Drugs and why are companies discussing it?
Weight-loss and diabetes drugs (Wegovy, Mounjaro, Zepbound) reshaping consumer demand, retail pharmacy economics and bioprocess equipment orders.
Which company mentioned glp-1 drugs most in Financials in the past year?
VNV Global AB (publ) (VNV) led with 4 calls referencing glp-1 drugs, most recently on July 14, 2026.
How can I track glp-1 drugs mentions across earnings calls via API?
The EarningsCalls.dev REST API exposes the same data behind this page. Use the search_transcripts and count_mentions_by_ticker endpoints to query our archive of 33,000+ earnings call transcripts — keyword search, sector / date filters, per-company mention counts, and the underlying full transcripts. See the API docs →
Related healthcare themes
Last updated: September 23, 2026. Methodology: full-text search across all earnings call transcripts in our corpus over the past 12 months, matching the canonical term and its aliases (GLP, glp-1, glp1, glp 1). Mentions are per call, not per occurrence within a call; the company-rank table is built by counting distinct calls mentioning the theme. Page refreshes every hour at the edge as new calls land in our archive.